SOCS1 and prostate carcinoma: Another study indicated that let‐7b‐5p may regulate M2 polarization through the SOCS1/STAT pathway and that let‐7b‐5p inhibitors reverse M2 differentiation while enhancing macrophage phagocytic activity, ultimately suppressing prostate cancer cell proliferation [39].